Lees Pharmaceutical Holdings Stock Profit Margin
| LPCUFDelisted Stock | USD 0.0001 0.00 0.00% |
Lees Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Lees Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Lees Pink Sheet. The fundamental analysis module provides a way to measure Lees Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lees Pharmaceutical pink sheet.
Lees |
Lees Pharmaceutical Holdings Company Profit Margin Analysis
Lees Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Lees Pharmaceutical Profit Margin | (0.09) % |
Most of Lees Pharmaceutical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lees Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Lees Pharmaceutical Holdings has a Profit Margin of -0.0883%. This is 99.21% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 93.05% lower than that of the firm.
Lees Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lees Pharmaceutical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lees Pharmaceutical could also be used in its relative valuation, which is a method of valuing Lees Pharmaceutical by comparing valuation metrics of similar companies.Lees Pharmaceutical is currently under evaluation in profit margin category among its peers.
Lees Fundamentals
| Return On Equity | -0.0531 | |||
| Return On Asset | 0.0591 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (1.58) % | |||
| Current Valuation | 123.64 M | |||
| Shares Outstanding | 588.84 M | |||
| Shares Owned By Insiders | 63.62 % | |||
| Shares Owned By Institutions | 6.36 % | |||
| Price To Book | 0.0002 X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 1.27 B | |||
| Gross Profit | 806.28 M | |||
| EBITDA | 1.98 B | |||
| Net Income | 1.99 B | |||
| Cash And Equivalents | 368.05 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 84.09 M | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 1.04 X | |||
| Book Value Per Share | 3.64 X | |||
| Cash Flow From Operations | 210.68 M | |||
| Number Of Employees | 1.32 K | |||
| Beta | 0.91 | |||
| Market Capitalization | 275.66 B | |||
| Total Asset | 3.64 B | |||
| Annual Yield | 52.23 % | |||
| Net Asset | 3.64 B | |||
| Last Dividend Paid | 0.041 |
About Lees Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lees Pharmaceutical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lees Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lees Pharmaceutical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Lees Pink Sheet
If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |